Weave Bio

Weave Bio operates an AI-native regulatory platform intended to help life sciences teams prepare and manage regulatory dossiers across the therapeutic life cycle. The product uses eCTD-formatted templates and uploaded source files to generate entire documents or sections, complex tables and summaries, and to insert figures, with the stated aim of speeding data organization, authoring, review, publishing and response management.

The platform includes verification and traceability functions: content is automatically checked against source data, potential issues are flagged, and any statement can be traced back to its origin. Collaboration features cover comments, version restoration, change tracking, real-time progress tracking and template sharing. When new data arrives, users can upload updated source files, regenerate affected content and review or accept the resulting changes. The company describes managing programs of any stage or modality in a single system, with lifecycle-stage coverage listed as forthcoming and platform enhancements released every few weeks based on customer feedback.

Business model

Weave Bio sells access to its regulatory authoring and submission platform to organizations in drug development, with packaging differentiated by customer type: enterprise-grade automation for biotech, multi-program orchestration with integrations and compliance controls for pharma, and a white-labeled, multi-client version for CROs and consultants.

Traction

Published testimonials reference use by Trace Biosciences, a top-20 pharmaceutical company's regulatory and product development operations staff, and a small biotech CEO.